Study reveals gaps in Follow-Up care for kids with rheumatoid purpura
NCT ID NCT05737056
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study observed 66 children diagnosed with rheumatoid purpura in three French hospital emergency rooms. Researchers tracked how well doctors followed official care guidelines and surveyed family doctors about their knowledge of the condition. The goal was to identify obstacles to proper follow-up after the child leaves the hospital.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
66 people
The number who actually took part.
- Started
-
May 2023
- Finished
-
Jul 2023
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients will be identified by the Medical Information Department of each site. The study will be conducted on patients who have been managed for rheumatoid purpura within the last two years at one of the three participating centers.
- Ages
-
0 to 18 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Underaged patient diagnosed with rheumatoid purpura during a visit to the pediatric emergencies of Mulhouse, Colmar and Strasbourg * No objection to the study from the two holders of parental authority Exclusion Criteria: \- Patient followed in the context of a genetic or malformative pathology, an immune deficiency, or a cancer
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Rheumatoid purpura are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital de Hautepierre
Strasbourg, 67200, France
-
Hôpitaux Civils de Colmar
Colmar, 68000, France